Allovir, Inc. — Form D
Allovir, Inc. of Houston, TX, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-02. The offering totals $50.0M, of which $30.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-10-02
- Form: D
- Accession: 0001754068-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $30.0M
- Remaining: $20.0M
- Investors: 1
- Date of first sale: 2018-09-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-322562
Issuer
- Name: Allovir, Inc.
- CIK: 0001754068
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 2925 Richmond Ave., Houston, TX, 77098
- Phone: 651-628-9259
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| John Wilson | Director | Frisco, TX |
| Ansbert Gadicke | Director | Morristown, NJ |
| Juan Vera | Director | Houston, TX |
| Morana Jovan-Embiricos | Director | Monaco, O9 |
| David Hallal | Director | Cambridge, MA |
| David Hallal | Executive Officer | Cambridge, MA |
| Vikas Sinha | Director | Houston, TX |
| Vikas Sinha | Executive Officer | Houston, TX |
| Malcom Brenner | Director | Houston, TX |
Other filings by this issuer (1)
More